SCHEMBL3822759

SCHEMBL3822759

Cc1nc(C(N)=O)oc1C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.46
KDM4E B2RXH2 2/20 0.46
POLB P06746 2/20 0.37
CYP1A2 P05177 1/20 0.34
HPGD P15428 2/20 0.34
TSHR P16473 2/20 0.34
GABRP O00591 1/20 0.33
GABRD O14764 1/20 0.33
GABRA1 P14867 1/20 0.33
GABRB1 P18505 1/20 0.33
GABRG2 P18507 1/20 0.33
GABRB3 P28472 1/20 0.33
GABRA5 P31644 1/20 0.33
GABRA3 P34903 1/20 0.33
GABRA2 P47869 1/20 0.33
GABRB2 P47870 1/20 0.33
GABRA4 P48169 1/20 0.33
GABRE P78334 1/20 0.33
GABRA6 Q16445 1/20 0.33
GABRG1 Q8N1C3 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2139887 0.78 KDM4E (0.53) ALDH1A1KDM4EPOLBMAPTL3MBTL1
SCHEMBL3822179 0.78 FBP1 (0.41) ALDH1A1KDM4ECYP1A2HPGDGAA
SCHEMBL2714738 0.74 GABRP (0.39) ALDH1A1KDM4EPOLBCYP1A2HPGD
SCHEMBL3822923 0.73 ALDH1A1 (0.41) ALDH1A1KDM4EPOLBHPGDTSHR
SCHEMBL286999 0.73 HSD17B10 (0.47) ALDH1A1POLBCYP1A2HPGDTSHR
Hydrochloric Acid SCHEMBL10496189 0.71 HSD17B10 (0.46) ALDH1A1POLBCYP1A2HPGDTSHR
SCHEMBL11166176 0.70 CYP1A2 (0.37) ALDH1A1KDM4EPOLBCYP1A2HPGD
SCHEMBL114334 0.70 MAPT (0.44) ALDH1A1KDM4EPOLBHPGDTSHR
SCHEMBL13366301 0.70 GAA (0.39) ALDH1A1KDM4EPOLBCYP1A2HPGD
SCHEMBL16437815 0.70 SMN1; SMN2 (0.37) ALDH1A1KDM4EHPGDTSHRGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2096111-A1 PYRAZOLES AND USE THEREOF AS DRUGS Japan Tobacco Inc. (JP) 2009-09-02 EP claimed
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF JAPAN TOBACCO, INC. (JP) 2009-02-05 US claimed
EP-2096111-A1 PYRAZOLES AND USE THEREOF AS DRUGS Japan Tobacco Inc. (JP) 2009-09-02 EP disclosed
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF JAPAN TOBACCO, INC. (JP) 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF PYGL, GYS2, G6PC1 ALDH1A1 775/4885KDM4E 1955/4885POLB 2667/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.